GlassScriptPhysician profile
James L Collier
NPI 1740288117
$963.31
in general payments reported to CMS, 2019-2025
13 companies · $157 in 2025
The $157 reported for 2025 was more than what 85% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $225 · 2022: $87.94 · 2023: $115 · 2024: $378 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $233.35 | 2023-2025 | Entyvio |
| Acacia Pharma INC | $171.52 | 2021 | |
| Merck Sharp & Dohme LLC | $144.88 | 2022-2024 | Bridion |
| Abbvie INC. | $103.55 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $79.99 | 2021-2024 | Xifaxan |
| Ardelyx, INC. | $66.32 | 2023-2024 | Ibsrela |
| Pacira Pharmaceuticals Incorporated | $38.19 | 2025 | Exparel |
| Heron Therapeutics, INC. | $28.50 | 2024 | Aponvie |
| Octapharma USA, INC. | $25.95 | 2025 | Fibryga |
| Becton, Dickinson and Company | $23.57 | 2025 | Hemosphere |
| Avanos Medical | $18.04 | 2023 | On-Q* Pump and Accessories |
| Braintree Laboratories, INC. | $15.15 | 2021 | |
| Organon LLC | $14.30 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Collier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.